Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Palestine flag Palestine · Delayed Price · Currency is JOD · Price in USD
4.650
0.00 (0.00%)
At close: Feb 26, 2026
23.02%
Market Cap 59.30M
Revenue (ttm) 35.40M
Net Income (ttm) 7.25M
Shares Out 18.00M
EPS (ttm) 0.40
PE Ratio 8.19
Forward PE n/a
Dividend 0.06 (1.72%)
Ex-Dividend Date Apr 30, 2025
Volume 2,100
Average Volume 2,035
Open 4.650
Previous Close n/a
Day's Range 4.650 - 4.650
52-Week Range 3.550 - 4.820
Beta -0.02
RSI 55.94
Earnings Date Mar 10, 2026

About Jerusalem Pharmaceuticals

Jerusalem Pharmaceuticals Co. Ltd., together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. The company offers over the counter, prescription pharmaceutical, and nutritional supplements products in various dosage forms, including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, and ointments, as well as ear and nose drops and solutions. It also provides medical devices... [Read more]

Industry Pharmaceutical Preparations
Founded 1969
Employees 531
Stock Exchange Palestine Stock Exchange
Ticker Symbol JPH
Full Company Profile

Financial Performance

In 2025, Jerusalem Pharmaceuticals's revenue was $49.93 million, an increase of 25.39% compared to the previous year's $39.82 million. Earnings were $10.23 million, an increase of 103.10%.

Financial numbers in USD Financial Statements

News

There is no news available yet.